HORIZON
VICT3R
Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 42 months
- Total cost
- EUR 26,060,885
- EU contribution
- EUR 13,524,750
- Participants
- 25 from 10 countries
- Topic
- HORIZON_HORIZON-JU-IHI-2023-05-01
- Grant agreement
- 101172693
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Zoetis Belgium SA | BEBelgium | Participant | Not stated | PIC (1.00) |
| Basf Se | DEGermany | Participant | EUR 0 | known name (0.95) |
| Bayer Aktiengesellschaft | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Merck Electronics Kgaa | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Merck Healthcare Kgaa | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Merck Life Science KGaA | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Sanofi-Aventis Deutschland GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Syncwork Aktiengesellschaft | DEGermany | Participant | EUR 835,000 | PIC (1.00) |
| Medbioinformatics Solutions SL | ESSpain | Participant | EUR 686,250 | PIC (1.00) |
| Institut Servier de Medecine Translationnelle | FRFrance | Participant | Not stated | PIC (1.00) |
| Ipsen Innovation Sas | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Astrazeneca UK Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Deciphex Limited | IEIreland | Participant | EUR 1,211,250 | PIC (1.00) |
| Phuse Cuideachta Faoi Theorainn Rathaiochta | IEIreland | Participant | EUR 621,500 | PIC (1.00) |
| Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. | ITItaly | Associated partner | EUR 0 | PIC (1.00) |
| Incyte Biosciences Distribution B.V | NLNetherlands | Participant | EUR 0 | PIC (1.00) |
| Organon SRL | RORomania | Participant | EUR 751,875 | PIC (1.00) |
| Abbvie Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Bristol-Myers Squibb Company Corp | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Incyte Corporation | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Janssen Research & Development, LLC | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
| Pfizer Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 25 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.